We also found that TRF-mediated inhibition of Dgat2 prevents lipid metabolism dysfunction in the periphery and prevents age and obesity-associated dysfunction [67]. This evidence concerns the gene DGAT2 and obesity due to melanocortin 4 receptor deficiency.